Latest Blog Posts Tagged "Research News"
October 26, 2016
An MJFF-funded study identified a new factor that may affect age of PD onset in individuals who carry a LRRK2 mutation.
October 11, 2016
In this podcast, MJFF staff scientist Marco Baptista, PhD, discusses the genetics and biology of LRRK2 and the role of the Foundation in advancing development of LRRK2 therapeutics.
October 04, 2016
Carmen Drahl wrote an article on how MJFF has supported continued work in autophagy, an area for which Japanese biologist Yoshinori Ohsumi, PhD, won a 2016 Nobel Prize.
October 03, 2016
Dale B. Schenk, PhD, a leader in the movement to treat neurodegenerative diseases with antibodies, died September 30.
September 30, 2016
Researchers in the Netherlands today announced a study modeled after and complimentary to the MJFF-led Parkinson's Progression Markers Initiative.
September 21, 2016
A new formulation of amantadine to better treat levodopa-induced dyskinesia is entering the home stretch.
September 08, 2016
A new study, funded in part by MJFF, identified a potential common link across different causes of Parkinson's.
September 07, 2016
Austrian biotech AFFiRiS reports a boost dose of its vaccine against key protein alpha-synuclein is safe and elicits antibodies. MJFF funded the trial.
September 01, 2016
In the last few months, Cynapsus Therapeutics Inc. has announced Phase II results of its under-the-tongue strip to alleviate motor symptoms, FDA Fast Track Designation and a buyout.
August 29, 2016
An MJFF-funded study reports promising results around development of a test to detect Parkinson's by measuring the properties of key protein alpha-synuclein.